Efficacy of Zinc Fortified Fermented Wheat Flour
EZAFFAW
EZAFFAW - Efficacy of Zinc Fortified Fermented Wheat Flour: Randomized Controlled Trial
1 other identifier
interventional
1,044
1 country
1
Brief Summary
Zinc is a pivotal micronutrient that participates in numerous essential metabolic pathways within the human body. Its multifaceted role makes the manifestations of zinc deficiency remarkably nonspecific and age-dependent. In children, zinc deficiency can manifest as growth retardation, cognitive impairment, recurrent infections, and other diverse symptoms. Adolescents and adults may experience fertility issues, work capacity impairment, and metabolic disorders due to zinc deficiency. Furthermore, zinc plays a crucial role in maintaining immune function, particularly in the elderly, where recurrent infections can be a notable outcome of deficiency. Given its fundamental importance, the potential benefits of zinc supplementation and fortification strategies have been explored, with some evidence indicating positive effects on health outcomes such as childhood mortality, diarrhea morbidity, and even risk factors for conditions like Type 2 Diabetes (T2DM) and cardiovascular disease (CVD). Understanding zinc's significance in these metabolic processes is vital for addressing deficiencies and improving public health. A study is needed to assess the effect of various types of fermented and unfermented wheat flour flatbread and its impact on health including zinc status, anthropometric outcomes, risk of T2DM and CVD and morbidity on adolescent and adult females. The whole wheat flatbread trial would be ideal to inform policy as it is regularly consumed in Sindh as most people rely on chakki for wheat grinding and it is used commonly to make roti at home.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
September 22, 2023
CompletedFirst Posted
Study publicly available on registry
October 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2024
CompletedJune 4, 2024
June 1, 2024
1.4 years
September 22, 2023
June 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Zinc Status
The primary outcome is the measurement of serum zinc status (micrograms per deciliter (μg/dL) in participants. This includes assessing the concentration of zinc in serum samples. Changes in serum zinc levels will be compared between the four intervention groups.
Baseline and six months post intervention
Fasting Blood Glucose
This outcome assesses changes in participants' fasting blood glucose levels, measured in milligrams per deciliter (mg/dL). It aims to understand alterations in blood glucose levels resulting from flatbread interventions.
Baseline and six months post-intervention.
HbA1C Levels
This measure evaluates HbA1C levels, expressed as a percentage (%). It provides insights into long-term blood glucose control, helping assess the impact of dietary interventions.
Baseline and six months post-intervention.
Insulin Levels
This measure assesses participants' insulin levels, measured in microunits per milliliter (μU/mL). It helps in understanding changes in insulin sensitivity as a result of dietary interventions.
Baseline and six months post-intervention.
Lipid Profiles
This measure assesses participants' lipid profiles, with the unit of measure to be specified (e.g., milligrams per deciliter, mg/dL). It provides insights into changes in lipid levels and their potential effects on overall body composition due to dietary interventions.
Six months post-intervention.
Zinc Deficiency (%)
This primary outcome evaluates the prevalence of zinc deficiency among participants and it would be compared across the four groups.
Baseline and six months post intervention
Red blood cell membrane fatty acids concentrations
This outcome measures the red blood cell membrane fatty acids concentrations as a percentage (%) and This would be compared across the four groups.
At six months post intervention
Secondary Outcomes (7)
Change in Weight (kg)
Six months post intervention
Change in Height (m)
Six months post intervention
Change in BMI (kg/m²)
Six months post intervention
Acceptability and Adherence Assessment
Six months post intervention
School Attendance and Academic Performance
Six months post intervention
- +2 more secondary outcomes
Study Arms (4)
Fermented High Zinc Wheat Flour Flatbread
EXPERIMENTALParticipants in this arm will receive fermented whole wheat flatbreads made from wheat variants with a high zinc content, ranging. These flatbreads are prepared through traditional fermentation methods.
Unfermented High Zinc Wheat Flour Flatbread
EXPERIMENTALParticipants in this arm will receive unfermented whole wheat flatbreads made from wheat variants with a high zinc content. These flatbreads provide a source of bioavailable zinc without the fermentation process.
Fortified Wheat Flour flatbread
EXPERIMENTALParticipants in this arm will receive flatbreads made from whole wheat flour fortified post-harvest to contain a zinc content
Low Zinc Wheat flatbread
ACTIVE COMPARATORParticipants in this arm will receive whole wheat flatbreads made from wheat variants with a low zinc content
Interventions
* Participants in this group will receive flatbreads made from fermented high zinc wheat flour. * The flatbreads will be prepared using traditional fermentation methods. * These flatbreads will be provided to participants to consume daily, along with vegetables or pulses (daal), for six days a week over the course of six months.
* Participants in this group will receive flatbreads made from unfermented high zinc wheat flour, * The flatbreads will not undergo a fermentation process. * These flatbreads will be provided to participants to consume daily, along with vegetables or pulses (daal), for six days a week over the course of six months.
* Participants in this group will receive flatbreads made from whole wheat flour fortified post-harvest * These fortified flatbreads will be provided to participants for daily consumption, along with vegetables or pulses (daal), for six days a week over the course of six months.
* Participants in this group will serve as the control group. * They will receive flatbreads made from whole wheat flour with a low zinc content * These low zinc flatbreads will be provided to participants for daily consumption, along with vegetables or pulses (daal), for six days a week over the course of six months. six days a week over the course of six months.
Eligibility Criteria
You may qualify if:
- Adolescents aged 10-19 years
- Adult women aged 20-40 years.
- Wheat as a staple part of their diet
You may not qualify if:
- Severe Malnutrition
- Pregnant or Lactating
- Chronic Diseases
- Participation in Similar Programs
- Individuals taking vitamin or mineral supplements at the time of enrollment
- Planned Relocation from the study area within the next 6-7
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aga Khan Universitylead
- Bahauddin Zakariya Universitycollaborator
- University of Californiacollaborator
- The Hospital for Sick Childrencollaborator
Study Sites (1)
Aga Khan University
Karachi, Sindh, 74800, Pakistan
Related Publications (1)
Das JK, Padhani ZA, Khan M, Mirani M, Rizvi A, Chauhadry IA, Yasin R, Ismail T, Akhtar S, Begum K, Iqbal J, Humayun K, Naseem HA, Malik KA, Bhutta ZA. Efficacy of Zinc Fortified and Fermented Wheat Flour (EZAFFAW): A randomized controlled trial protocol. PLoS One. 2024 Jun 20;19(6):e0304462. doi: 10.1371/journal.pone.0304462. eCollection 2024.
PMID: 38900773DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jai K Das
Aga Khan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- This clinical trial will be conducted with a double-blind design Participant Blinding: Participants will not be informed about which specific type of flatbread they are receiving. Each participant will receive their assigned flatbread without knowledge of whether it falls into the fermented high zinc, unfermented high zinc, post-harvest fortified, or low zinc category. Investigator and outcomes assessor Blinding: The investigators and research staff responsible for data collection and assessment will also be unaware of the treatment assignments. They will not be involved in the preparation of the flatbreads to ensure that their observations and assessments are unbiased.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor and Assistant Director
Study Record Dates
First Submitted
September 22, 2023
First Posted
October 23, 2023
Study Start
January 1, 2023
Primary Completion
May 31, 2024
Study Completion
May 31, 2024
Last Updated
June 4, 2024
Record last verified: 2024-06